Restricting access to antibiotics: The effectiveness of a 'no repeats' government policy intervention.

Contreras, Juliet; Oguoma, Victor; Todd, Lyn; Naunton, Mark; Collignon, Peter; Bushell, Mary

Contreras, Juliet; Oguoma, Victor; Todd, Lyn; Naunton, Mark; Collignon, Peter; Bushell, Mary.

Afiliação

Contreras J; Faculty of Pharmacy, University of Canberra, ACT, Australia. Electronic address: Juliet.Contreras100@gmail.com.
Oguoma V; Health Research Institute, University of Canberra, ACT, Australia. Electronic address: Victor.Oguoma@canberra.edu.au.
Todd L; Faculty of Pharmacy, University of Canberra, ACT, Australia. Electronic address: Lyn.Todd@canberra.edu.au.
Naunton M; Faculty of Pharmacy, University of Canberra, ACT, Australia. Electronic address: Mark.Naunton@canberra.edu.au.
Collignon P; ANU Medical School, ANU College of Health & Medicine, ACT, Australia; Australian Capital Territory Pathology, Canberra Hospital, Garran, Australian Capital Territory, Australia. Electronic address: peter.collignon@act.gov.au.
Bushell M; Faculty of Pharmacy, University of Canberra, ACT, Australia. Electronic address: Mary.Bushell@canberra.edu.au.

Res Social Adm Pharm ; 19(5): 800-806, 2023 05.

Article em En | MEDLINE | ID: mdl-36828673

Assuntos

Antibacterianos; COVID-19; Humanos; Antibacterianos/uso terapêutico; Estudos Retrospectivos; Pandemias; Austrália; Políticas; Governo

Palavras-chave

AMS; Antibiotics; Government policy change; Pharmaceutical benefits scheme

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Antibacterianos Tipo de estudo: Evaluation_studies / Observational_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Res Social Adm Pharm Assunto da revista: FARMACIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google